List of insiders holdings for Enliven Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director 10% Owner |
2024-05-20 16:55:58 | 7,918,163 0 |
7,918,163 | Form 13D |
2 | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
2024-05-20 17:00:24 | 0 7,663,349 |
7,663,349 | Form 4 |
3 | Bonita David P Director 10% Owner |
2022-06-03 20:18:19 | 8,500 4,199,068 |
4,207,568 | Form 4 |
4 | COMMODORE CAPITAL LP 10% Owner |
2024-11-14 16:05:18 | 4,100,000 0 |
4,100,000 | Form 13G |
5 | Chin Mark Director |
2022-06-03 20:19:10 | 8,500 2,344,072 |
2,352,572 | Form 4 |
6 | Arix Bioscience plc Arix Bioscience Holdings Ltd 10% Owner |
2021-07-20 16:21:12 | 2,344,072 0 |
2,344,072 | Form 13D |
7 | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. PARMAR KUSH Schwab Andrew J. 10% Owner |
2024-07-29 18:12:42 | 2,304,332 0 |
2,304,332 | Form 13D |
8 | Leonard Braden Michael 10% Owner |
2023-01-05 20:03:17 | 230,000 1,767,774 |
1,997,774 | Form 4/A |
9 | Dalton Barbara Director |
2022-06-03 20:20:32 | 8,500 1,557,722 |
1,566,222 | Form 4 |
10 | Agger Mette Kirstine Director 10% Owner |
2020-03-16 17:15:42 | 15,457 1,432,722 |
1,448,179 | Form 4 |
11 | Lundbeckfond Invest A/S 10% Owner |
2021-02-03 16:31:51 | 1,432,722 0 |
1,432,722 | Form 13G |
12 | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Former 10% owner |
2024-11-14 17:46:11 | 1,061,233 0 |
1,061,233 | Form 13G |
13 | Lyssikatos Joseph P CHIEF SCIENTIFIC OFFICER |
2025-03-21 17:49:04 | 0 1,002,688 |
1,002,688 | Form 4 |
14 | Kintz Samuel PRESIDENT AND CEO |
2025-03-19 17:42:50 | 0 990,392 |
990,392 | Form 4 |
15 | GOLDFISCHER CARL BAY CITY CAPITAL LLC Bay City Capital Management V LLC Bay City Capital Fund V L.P. Bay City Capital Fund V Co-Investment Fund L.P. Director 10% Owner |
2020-03-16 17:12:34 | 0 718,837 |
718,837 | Form 4 |
16 | GOLDFISCHER CARL Director |
2022-06-03 20:21:19 | 8,500 703,380 |
711,880 | Form 4 |
17 | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner |
2020-03-16 17:04:56 | 0 523,411 |
523,411 | Form 4 |
18 | H LUNDBECK A S 10% Owner |
2020-03-16 17:03:34 | 522,499 0 |
522,499 | Form 4 |
19 | PFIZER INC Pfizer Ventures (US) LLC 10% Owner |
2024-02-14 15:31:31 | 389,429 0 |
389,429 | Form 13G |
20 | Patel Anish CHIEF OPERATING OFFICER |
2025-04-09 16:25:40 | 0 316,643 |
316,643 | Form 4 |
21 | Alexandria Venture Investments LLC 10% Owner |
2020-03-16 17:03:30 | 293,013 0 |
293,013 | Form 4 |
22 | MOTT DAVID M Director |
2022-06-03 20:17:36 | 237,724 0 |
237,724 | Form 4 |
23 | Scheele Willem Chief Medical Officer |
2020-03-11 18:21:08 | 207,129 0 |
207,129 | Form 3 |
24 | Collins Helen Louise CHIEF MEDICAL OFFICER |
2025-02-10 17:25:35 | 171,000 0 |
171,000 | Form 4 |
25 | Hohl Benjamin CHIEF FINANCIAL OFFICER |
2025-03-31 19:37:34 | 151,556 0 |
151,556 | Form 4 |
26 | Adams Christoph M 10% Owner |
2020-03-11 18:19:52 | 100,433 0 |
100,433 | Form 3 |
27 | Attie Kenneth SVP, CMO |
2022-02-01 18:26:36 | 68,200 0 |
68,200 | Form 4 |
28 | GRAY MICHAEL CFO & COO |
2023-02-22 20:26:54 | 27,610 0 |
27,610 | Form 4 |
29 | Heyman Richard A. Director |
2025-02-10 17:38:18 | 23,014 0 |
23,014 | Form 4 |
30 | Bauer Jake Director |
2025-02-10 17:34:28 | 20,491 0 |
20,491 | Form 4 |
31 | Phillips Andrew John Director |
2025-02-10 17:40:43 | 20,491 0 |
20,491 | Form 4 |
32 | Gupta Rishi Director 10% Owner |
2025-02-10 17:36:29 | 20,491 0 |
20,491 | Form 4 |
33 | Derynck Mika K Director |
2025-02-10 17:35:32 | 20,491 0 |
20,491 | Form 4 |
34 | Ballal Rahul D. Director |
2025-02-10 17:33:23 | 20,491 0 |
20,491 | Form 4 |
35 | McArthur James G Director |
2020-03-16 17:11:57 | 15,457 0 |
15,457 | Form 4 |
36 | Kunkel Lori Anne Director |
2025-02-10 17:39:40 | 15,368 0 |
15,368 | Form 4 |
37 | Conner Edward R. Director |
2022-06-03 20:19:47 | 8,500 0 |
8,500 | Form 4 |
38 | Williams Laura A Director |
2022-06-03 20:22:18 | 8,500 0 |
8,500 | Form 4 |
39 | Nayeem Sara M. Director |
2021-06-30 20:08:47 | 7,728 0 |
7,728 | Form 4 |
40 | New Enterprise Associates 14 L.P. BASKETT FOREST Florence Anthony A. Jr. KERINS PATRICK J SANDELL SCOTT D Sonsini Peter W. NEA 14 GP LTD NEA Partners 14 L.P. 10% Owner |
2022-05-24 17:11:28 | 0 0 |
0 | Form 13D |